News
Merger of Celon Services and Celon Pharma
The Company’s Management Board announces that the process aiming at the merger of Celon Services and Celon Pharma began on 1 July 2012, pursuant to Article 492 par. 1 point 1 of the Code of Commercial Companies. Download the Merger plan Celon Pharma Sp. z o. o 05-092 Kiełpin Ul. Ogrodowa 2A NIP 118 16Read more »
Celon Pharma received the Polish Agency for Enterprise Development (PARP)’s award for the most innovative project
On 15 May this year, the official award ceremony in a competition organised by the Polish Agency for Enterprise Development in cooperation with the Polish Society for Supporting Entrepreneurship took place. The goal of the competition was to honour modern and innovative business solutions. Celon Pharma received the main award in the “Innovative pharmaceutical andRead more »
Celon Pharma on MKNOL
Celon Pharma is going to present on VIII Multidisciplinary Conference on Drug Science (MKNOL) in Hotel Ossa & Spa near Rawa Mazowiecka. We’ve prepared two lectures: CPL-200-075, a novel potent renal sodium-glucose cotransporter 2 (SGLT2) inhibitor and Design and development of CPL-407-22 – novel, potent and selective JAK2 protein kinase inhibitor.
We have launched a Computer-assisted Drug Design Lab
We have launched a Computer-assisted Drug Design Department. The unit’s task will be to support, in terms of bioinformatics and chemoinformatics, the process of designing active substances: developing methodology, conducting and analysing virtual screening, analysing the binding of active particles with proteins, estimating and assessing ADMET parameters, creating QSAR models. The Department has a wideRead more »